{"id":56033,"date":"2026-01-12T10:35:13","date_gmt":"2026-01-12T09:35:13","guid":{"rendered":"https:\/\/editing.capitalmind.com\/?post_type=deals&#038;p=56033"},"modified":"2026-01-12T17:53:13","modified_gmt":"2026-01-12T16:53:13","slug":"sale-of-swiss-oncology-group-to-hirslanden","status":"publish","type":"deals","link":"https:\/\/www.investec.com\/advisory\/deals\/sale-of-swiss-oncology-group-to-hirslanden\/","title":{"rendered":"Majority sale of leading Swiss oncology group, creating a strategic partnership with Hirslanden\u00a0"},"content":{"rendered":"\n<p>Investec advised the owners of&nbsp;<em>Klinik f\u00fcr H\u00e4matologie und Onkologie Hirslanden Z\u00fcrich<\/em> and&nbsp;of <em>Onkozentrum Z\u00fcrich<\/em>&nbsp;on the majority sale to the owner family of Hirslanden.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">About the deal<\/h2>\n\n\n\n<p>Investec acted as the exclusive financial advisor to Klinik f\u00fcr H\u00e4matologie und Onkologie Hirslanden Z\u00fcrich and Onkozentrum Z\u00fcrich on their combined majority sale to the owner family of Hirslanden Group.<\/p>\n\n\n\n<p>The two leading Swiss cancer care institutions offer together the complete range of services in oncology and hematology including highly specialized and most advanced diagnostic and treatment options. With a team of ca. 20 highly experienced medical oncologists (many of them international key opinion leaders in their field), over 11\u2019000 therapies are performed annually at five locations in the canton of Zurich for all cancer types.<\/p>\n\n\n\n<p>Hirslanden is the largest private clinic group in Switzerland with 17 hospitals, many of which have an emergency department. It also operates 5 outpatient surgery centres, 19 radiology and 6 radiotherapy institutes. The Group has 2\u2019651 partner doctors and 11\u2019146 employees.<\/p>\n\n\n\n<p>The strategic partnership between the oncology centers and Hirslanden will allow for high-quality medical care while focusing on entrepreneurial continuity: as co-shareholders the doctor-owners will continue to ensure the medical and entrepreneurial success of their centres.<\/p>\n\n\n<section class=\"content--block quoteBlock \">\n    <div class=\"holder\">\n        <div class=\"stories slide-up d-flex\" data-scroll=\"\">\n            \n            <blockquote class=\"stories__desc\" style=\"flex: 0 0 100%;max-width: 100%;\">\n                <span class=\"stories__desc_quote\">\u201c\u201d<\/span>\n\n                                    <div class=\"justified\"><p>\u201cThe collaboration with the M&#038;A-Team of Investec was very positive. The team prepared and executed the project with high professionalism and efficiency, supporting both companies\u2019 shareholders with great commitment in all project phases. Thanks to their expertise, manpower and result-oriented approach, also in complex situations, we could realize an ideal transaction result with a strategically highly relevant partner. We greatly appreciated the personal and professional collaboration with Investec.\u201d<\/p>\n<\/div>                \n\n                                    <cite>&#8211; Prof. Dr. med. Christoph Renner, co-owner of Klinik f\u00fcr H\u00e4matologie und Onkologie Hirslanden Z\u00fcrich AG and of Onkozentrum Z\u00fcrich AG<\/cite>\n                            <\/blockquote>\n        <\/div><!-- \/.stories -->\n    <\/div>\n<\/section>\n<!-- ============= End of \/.QuoteBlock =============== -->\n\n\n<h2 class=\"wp-block-heading\">Our role<\/h2>\n\n\n\n<p>The Investec team advised the owners of the two oncology centers throughout the entire M&amp;A process until the successful completion of the transaction, including:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Preparation of business plan and marketing materials,<\/li>\n\n\n\n<li>Detailed analysis of Tardoc impact (Swiss healthcare reimbursement system),<\/li>\n\n\n\n<li>Identification of potential buyers (strategic and financial),<\/li>\n\n\n\n<li>Market approach and realization of a competitive sales process,<\/li>\n\n\n\n<li>Preparation and management of due diligence,<\/li>\n\n\n\n<li>Conducting price negotiations,<\/li>\n\n\n\n<li>Support in negotiations of the legal documentation,<\/li>\n\n\n\n<li>Coordination of all involved parties, incl. legal and tax advisors.<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investec advised the owners of&nbsp;Klinik f\u00fcr H\u00e4matologie und Onkologie Hirslanden Z\u00fcrich and&nbsp;of Onkozentrum Z\u00fcrich&nbsp;on the majority sale to the owner&#8230;<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[],"sector":[31],"dealtype":[33],"clienttype":[34],"class_list":["post-56033","deals","type-deals","status-publish","hentry","sector-healthcare","dealtype-sell-your-business","clienttype-founders-entrepreneurs"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sale of leading Swiss oncology group to Hirslanden | Investec Business Advisory<\/title>\n<meta name=\"description\" content=\"Investec advised the owners of KHO and Onkozentrum Z\u00fcrich on the majority sale to the owner family of Hirslanden.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.investec.com\/advisory\/deals\/sale-of-swiss-oncology-group-to-hirslanden\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sale of leading Swiss oncology group to Hirslanden | Investec Business Advisory\" \/>\n<meta property=\"og:description\" content=\"Investec advised the owners of KHO and Onkozentrum Z\u00fcrich on the majority sale to the owner family of Hirslanden.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.investec.com\/advisory\/deals\/sale-of-swiss-oncology-group-to-hirslanden\/\" \/>\n<meta property=\"og:site_name\" content=\"Investec Business Advisory\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-12T16:53:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/deals\\\/sale-of-swiss-oncology-group-to-hirslanden\\\/\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/deals\\\/sale-of-swiss-oncology-group-to-hirslanden\\\/\",\"name\":\"Sale of leading Swiss oncology group to Hirslanden | Investec Business Advisory\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/#website\"},\"datePublished\":\"2026-01-12T09:35:13+00:00\",\"dateModified\":\"2026-01-12T16:53:13+00:00\",\"description\":\"Investec advised the owners of KHO and Onkozentrum Z\u00fcrich on the majority sale to the owner family of Hirslanden.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/deals\\\/sale-of-swiss-oncology-group-to-hirslanden\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.investec.com\\\/advisory\\\/deals\\\/sale-of-swiss-oncology-group-to-hirslanden\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/deals\\\/sale-of-swiss-oncology-group-to-hirslanden\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Majority sale of leading Swiss oncology group, creating a strategic partnership with Hirslanden\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/#website\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/\",\"name\":\"Investec Business Advisory\",\"description\":\"Investec Business Advisory\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/#organization\",\"name\":\"Capitalmind Investec\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Logo_Investec_cmjn_6.jpg\",\"contentUrl\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Logo_Investec_cmjn_6.jpg\",\"width\":1120,\"height\":1121,\"caption\":\"Capitalmind Investec\"},\"image\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/capitalmind---corporate-finance-advisory\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC4bVt7iNejh8tGT6Qfa9R4w\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sale of leading Swiss oncology group to Hirslanden | Investec Business Advisory","description":"Investec advised the owners of KHO and Onkozentrum Z\u00fcrich on the majority sale to the owner family of Hirslanden.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.investec.com\/advisory\/deals\/sale-of-swiss-oncology-group-to-hirslanden\/","og_locale":"en_US","og_type":"article","og_title":"Sale of leading Swiss oncology group to Hirslanden | Investec Business Advisory","og_description":"Investec advised the owners of KHO and Onkozentrum Z\u00fcrich on the majority sale to the owner family of Hirslanden.","og_url":"https:\/\/www.investec.com\/advisory\/deals\/sale-of-swiss-oncology-group-to-hirslanden\/","og_site_name":"Investec Business Advisory","article_modified_time":"2026-01-12T16:53:13+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.investec.com\/advisory\/deals\/sale-of-swiss-oncology-group-to-hirslanden\/","url":"https:\/\/www.investec.com\/advisory\/deals\/sale-of-swiss-oncology-group-to-hirslanden\/","name":"Sale of leading Swiss oncology group to Hirslanden | Investec Business Advisory","isPartOf":{"@id":"https:\/\/www.investec.com\/advisory\/#website"},"datePublished":"2026-01-12T09:35:13+00:00","dateModified":"2026-01-12T16:53:13+00:00","description":"Investec advised the owners of KHO and Onkozentrum Z\u00fcrich on the majority sale to the owner family of Hirslanden.","breadcrumb":{"@id":"https:\/\/www.investec.com\/advisory\/deals\/sale-of-swiss-oncology-group-to-hirslanden\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.investec.com\/advisory\/deals\/sale-of-swiss-oncology-group-to-hirslanden\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.investec.com\/advisory\/deals\/sale-of-swiss-oncology-group-to-hirslanden\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.investec.com\/advisory\/"},{"@type":"ListItem","position":2,"name":"Majority sale of leading Swiss oncology group, creating a strategic partnership with Hirslanden\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.investec.com\/advisory\/#website","url":"https:\/\/www.investec.com\/advisory\/","name":"Investec Business Advisory","description":"Investec Business Advisory","publisher":{"@id":"https:\/\/www.investec.com\/advisory\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.investec.com\/advisory\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.investec.com\/advisory\/#organization","name":"Capitalmind Investec","url":"https:\/\/www.investec.com\/advisory\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.investec.com\/advisory\/#\/schema\/logo\/image\/","url":"https:\/\/www.investec.com\/advisory\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","contentUrl":"https:\/\/www.investec.com\/advisory\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","width":1120,"height":1121,"caption":"Capitalmind Investec"},"image":{"@id":"https:\/\/www.investec.com\/advisory\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory","https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w"]}]}},"_links":{"self":[{"href":"https:\/\/www.investec.com\/advisory\/wp-json\/wp\/v2\/deals\/56033","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investec.com\/advisory\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/www.investec.com\/advisory\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/www.investec.com\/advisory\/wp-json\/wp\/v2\/media?parent=56033"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/wp-json\/wp\/v2\/dt?post=56033"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/wp-json\/wp\/v2\/sector?post=56033"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/wp-json\/wp\/v2\/dealtype?post=56033"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/wp-json\/wp\/v2\/clienttype?post=56033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}